JSH BIOTECH ApS: Financial statements 2024
CVR: 25220129
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
JSH BIOTECH ApS (CVR 25220129) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 194,261 and a net result of DKK 1,154,367 compared with DKK -1,323,153 the year before. That is a decrease of 35.4% compared with the year before. Equity in the 2024 report amounted to DKK 3,376,641. The solvency ratio was 50.2%.
- Gross Profit
- DKK 194,261
- Profit/Loss
- DKK 1,154,367
- Equity
- DKK 3,376,641
- Total Assets
- DKK 6,724,252
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 194 t. | 1.2 mio. | 3.4 mio. | - |
| 2023 | - | 301 t. | -1.3 mio. | 2.3 mio. | - |
| 2022 | - | 341 t. | -3.3 mio. | 3.8 mio. | - |
| 2021 | - | 649 t. | 3.1 mio. | 7.2 mio. | - |
| 2020 | - | 578 t. | 3.2 mio. | 4.2 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
JSH BIOTECH ApS has published its annual report for 2023. Gross profit came to DKK 300,652, and the net result was DKK -1,323,153.
About JSH BIOTECH ApS
JSH BIOTECH ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2000. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named VICH 5941 ApS. The management consists of John Sørensen Haurum. The company is owned by John Sørensen Haurum. In 2025, the company reported a gross profit of DKK 620,332 and a net result of DKK 3,409,861 compared with DKK 1,154,367 the year before. Equity in the 2025 report amounted to DKK 6,651,503.